Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123169) titled 'Dual-mode detection of enantiomers' on April 22.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: The First Affiliated Hospital of Ningbo University
Condition:
Prostate cancer
Intervention:
Gold Standard:According to the clinical diagnostic criteria
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Target condition:150;Difficult condition:0
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319868
Published by HT Digital Content Services with permission from Hea...